Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide.

In conclusion, the genetic polymorphisms of CYP2D6 significantly affected metoclopramide pharmacokinetics. PMID: 33247397 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33247397?dopt=Abstract

Source: Archives of Pharmacal Research - November 27, 2020 Category: Drugs & Pharmacology Authors: Bae JW, Oh KY, Yoon SJ, Shin HB, Jung EH, Cho CK, Lim CW, Kang P, Choi CI, Jang CG, Lee SY, Lee YJ Tags: Arch Pharm Res Source Type: research